name,title,company,person_location,company_hq,funding_stage,publication_topic,publication_year,uses_invitro,email,work_mode,company_in_hub,probability_score,rank
Dr John Smith,Director of Toxicology,ABC Biotech,Boston,Cambridge MA,Series B,Drug Induced Liver Injury,2024,Yes,dr.john@abcbiotech.com,Remote,True,100,1
Dr Michael Brown,VP Preclinical Safety,OncoNova,Bay Area,Bay Area,Series B,Liver Safety Biomarkers,2024,Yes,dr.michael@onconova.com,Onsite,True,100,2
Dr Priya Nair,Head of Translational Safety,GenovaBio,Cambridge MA,Cambridge MA,Series B,Drug Induced Liver Injury,2024,Yes,dr.priya@genovabio.com,Onsite,True,100,3
Dr Andreas MÃ¼ller,Director of Investigative Toxicology,BioHelix,Munich,Basel,Series A,Drug Metabolism and Liver Injury,2024,Yes,dr.andreas@biohelix.eu,Remote,True,100,4
Dr Robert Wilson,Director of Safety Pharmacology,CardioLife,Boston,Boston,IPO,Organ-on-Chip Liver Models,2023,Yes,dr.robert@cardiolife.com,Onsite,True,100,5
Dr Emily Chen,Head of Safety Assessment,NeoPharma,Basel,Basel,Series A,Hepatic Toxicity Models,2023,Yes,dr.emily@neopharma.com,Onsite,True,65,6
Dr Laura Martinez,Senior Toxicologist,HepatoTech,San Diego,San Diego,Series C,In Vitro Hepatic Models,2022,Yes,dr.laura@hepatotech.com,Onsite,True,35,7
Dr Sarah Patel,Principal Scientist,TheraGen,London,UK Golden Triangle,Private,3D Cell Culture for Toxicology,2023,Yes,dr.sarah@theragen.co.uk,Remote,True,15,8
Jane Doe,Junior Scientist,StartupX,Texas,San Diego,Seed,Cell Culture Methods,2021,No,jane.doe@startupx.io,Remote,True,0,9
Dr Kevin Lee,Scientist,EarlyBio,Toronto,Toronto,Pre-Seed,Toxicology Screening,2021,No,dr.kevin@earlybio.ai,Onsite,False,0,10
